Duality Advisers’s AdaptHealth AHCO Stock Holding History

Duality Advisers’s Portfolio AHCO Stock Details AHCO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-21,488	Closed	-$267K	–	505
2023 Q1	$267K	Sell	21,488 -44,444	-67%	-$818K	0.03%	492
2022 Q4	$1.27M	Buy	+65,932	New	+$1.39M	0.14%	256

Other funds holding AHCO

OCA

OEP Capital Advisors New York $194M AUM 9.78% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

SkyKnight Capital San Francisco, California $107M AUM 9.69% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Truist Financial Charlotte, North Carolina $74.2B AUM 21.09% 1-Year Est. Return

Reinhart Partners Mequon, Wisconsin $4.38B AUM 55.55% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Duality Advisers's AHCO Position: Q2 2023 in Review

Duality Advisers sold out of AdaptHealth (AHCO) in Q2 2023, closing a stake of 21,488 shares — an estimated $267K sold.

Duality Advisers first reported a position in AHCO in Q4 2022 and held it in 2 quarters. The position peaked at $1.27M in Q4 2022. 182 funds tracked by Wall St. Rank hold AHCO as of Q2 2023.

Duality Advisers reported no remaining AdaptHealth position as of Q2 2023 after selling out during the quarter.
Duality Advisers sold 21,488 AdaptHealth shares in Q2 2023, an estimated $267K.
Duality Advisers first reported a position in AdaptHealth in Q4 2022 and held it in 2 quarters.
Duality Advisers's AdaptHealth position peaked at $1.27M in Q4 2022.
182 funds tracked by Wall St. Rank held AdaptHealth as of Q2 2023.

Based on Duality Advisers's 13F filing for Q2 2023, filed 31 Jul 2023.